TNDM

Tandem Diabetes Care, Inc.

54
Fundamentals66/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential38/ 100

TNDM lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.

TNDM Fundamentals

MetricStatus
Healthy
Stable
Under pressure
Strong

TNDM's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.

TNDM PE Valuation

TNDM has no meaningful PE right now: it lost money over the past year.

TNDM Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Low

Analysts expect TNDM's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

TNDM Risk to reward

ScenarioChangePrice
Upside+63%$28.50
Downside-38%$10.84

Calculated from the latest close: $17.51 on Nov 12.

TNDM's one-year upside scenario is somewhat larger than its downside: +63% against −38%.

TNDM Earnings Per Share

Q4 2023: $-3.44Q1 2024: $-2.17Q2 2024: $-2.09Q3 2024: $-1.93Q4 2024: $-1.46Q1 2025: $-2.78Q2 2025: $-3.09Q3 2025: $-3.05Q4 2025: $-3.07Q1 2026: $-1.40Q2 2026: $-0.93Q3 2026: $-0.72
Q4 2023: $-3.44Q1 2024: $-2.17Q2 2024: $-2.09Q3 2024: $-1.93Q4 2024: $-1.46Q1 2025: $-2.78Q2 2025: $-3.09Q3 2025: $-3.05Q4 2025: $-3.07Q1 2026: $-1.40Q2 2026: $-0.93Q3 2026: $-0.72
QuarterTTM EPSYoY
Q3 2026-$0.72+$2.33
Q2 2026-$0.93+$2.16
Q1 2026-$1.40+$1.38
Q4 2025-$3.07-$1.61
Q3 2025-$3.05-$1.12
Q2 2025-$3.09-$1.00
Q1 2025-$2.78-$0.61
Q4 2024-$1.46+$1.98

TNDM is still losing money, but far less than before: $0.72 per share over the past year, against $3.48 at its worst in mid-2023.

TNDM Quarterly Revenue

Q4 2023: $197MQ1 2024: $192MQ2 2024: $222MQ3 2024: $244MQ4 2024: $283MQ1 2025: $234MQ2 2025: $241MQ3 2025: $249MQ4 2025: $290MQ1 2026: $247MQ2 2026: $255MQ3 2026: $284M
Q4 2023: $197MQ1 2024: $192MQ2 2024: $222MQ3 2024: $244MQ4 2024: $283MQ1 2025: $234MQ2 2025: $241MQ3 2025: $249MQ4 2025: $290MQ1 2026: $247MQ2 2026: $255MQ3 2026: $284M
QuarterRevenueYoY
Q3 2026$283.7M+14%
Q2 2026$254.6M+5.8%
Q1 2026$247.2M+5.5%
Q4 2025$290.4M+2.7%
Q3 2025$249.3M+2.2%
Q2 2025$240.7M+8.5%
Q1 2025$234.4M+22%
Q4 2024$282.6M+44%

TNDM's revenue has grown year over year for 11 quarters in a row: $284M last quarter, up 14% from the same quarter a year ago.

TNDM Free Cash Flow

Q4 2023: −$12MQ1 2024: −$12MQ2 2024: −$12MQ3 2024: $22MQ4 2024: $8MQ1 2025: −$21MQ2 2025: −$16MQ3 2025: $4MQ4 2025: $3MQ1 2026: $5MQ2 2026: −$39MQ3 2026: −$6M
Q4 2023: −$12MQ1 2024: −$12MQ2 2024: −$12MQ3 2024: $22MQ4 2024: $8MQ1 2025: −$21MQ2 2025: −$16MQ3 2025: $4MQ4 2025: $3MQ1 2026: $5MQ2 2026: −$39MQ3 2026: −$6M
QuarterFree cash flowYoY
Q3 2026-$5.5M-232%
Q2 2026-$38.7M-$23M
Q1 2026$4.8M+$26M
Q4 2025$3.1M-59%
Q3 2025$4.2M-81%
Q2 2025-$15.7M-$4M
Q1 2025-$21.2M-$8.8M
Q4 2024$7.6M+$20.1M

TNDM's free cash flow was −$36M over the past year, against −$25M the year before.

TNDM Total Shares

Q4 2023: 65MQ1 2024: 65MQ2 2024: 65MQ3 2024: 66MQ4 2024: 66MQ1 2025: 66MQ2 2025: 67MQ3 2025: 68MQ4 2025: 68MQ1 2026: 68MQ2 2026: 69MQ3 2026: 70M
Q4 2023: 65MQ1 2024: 65MQ2 2024: 65MQ3 2024: 66MQ4 2024: 66MQ1 2025: 66MQ2 2025: 67MQ3 2025: 68MQ4 2025: 68MQ1 2026: 68MQ2 2026: 69MQ3 2026: 70M
PeriodChange %Net change
Quarterly+0.9%+639K shares
1 year+3%+2M shares
3 years+7%+4.5M shares
5 years+7.5%+4.9M shares
Available history+19%+11.1M shares

TNDM has 70M diluted shares, up 3% from a year ago.

TNDM Net Leverage

QuarterNet LeverageStatus
Q2 2022-16.5xNet Cash
Q1 2022-3.8xNet Cash
Q4 2021-2.0xNet Cash
Q3 2021-2.7xNet Cash
Q2 2021-3.0xNet Cash
Q1 2021-8.3xNet Cash
Q4 2020-37.9xNet Cash

TNDM has more cash than debt.

TNDM Weekly Momentum

MetricValueStatus
RSI48.4Neutral
Stochastic30.2Neutral

TNDM's weekly RSI is 48 (neutral) and its Stochastic is 30 (neutral).

TNDM PE vs Healthcare Sector

MetricTNDMSector medianRelative
PEN/A26x—

TNDM has no meaningful PE right now: it lost money over the past year.

TNDM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$16.93.4% above
20 week MA$18.13.4% below
50 week MA$19.18.4% below
100 week MA$19.912% below
200 week MA$26.534% below

TNDM has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 34% below its 200-week average.

TNDM Yearly ROI

YearStart priceEnd priceROI
2020$60.2$93.9+56%
2021$93.9$151.8+62%
2022$151.8$42.0-72%
2023$42.0$29.6-30%
2024$29.6$36.9+25%
2025$36.9$22.4-39%
2026 YTD$22.4$17.5-22%

TNDM has finished lower in three of the last six years. It's down 22% so far in 2026.

Give your agent the market.

Get API key